Qiagen N.V. (FRA:QIA)

Market Cap	9.13B
Revenue (ttm)	1.85B
Net Income (ttm)	86.67M
Shares Out	n/a
EPS (ttm)	0.39
PE Ratio	105.40
Forward PE	20.59
Dividend	1.42 (3.40%)
Ex-Dividend Date	Jul 2, 2025

Volume	n/a
Average Volume	993
Open	42.20
Previous Close	42.00
Day's Range	42.20 - 42.22
52-Week Range	32.50 - 47.53
Beta	n/a
RSI	61.70
Earnings Date	Jul 28, 2025

About Qiagen

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and...

• Industry: Laboratory Analytical Instruments
• Founded: 1984
• Employees: 5,396
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: QIA

Financial Performance

In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.

Financial numbers in USD